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Background: A number of life threatening infections due to various bacterial pathogens are major cause of death in Pakistan. In a situation like 
the other developing countries, there is a general increase in the drug resistance due to the irrational use of the antibiotics. The present 
study was carried out to evaluate the prevalence and development of resistance in Klebsiella pneumoniae against commonly used 
antibiotics.  
Methods and Materials: A total of 200 samples from different wards of the hospitals were received by the pathology laboratory of 
Pakistan Institute of Medical Sciences, Islamabad, which comprised of urine 65, blood 50 and other miscellaneous samples from 
various sources. Klebsiella pneumoniae was isolated and characterized using morphological, cultural, and biochemical methods and were further 
confirmed by using commercially available API 20E kit. The isolates were subjected to culture sensitivity test using Kirby Bauer disc 
diffusion method.  
Results: The organism was found to be the most prevalent Gram-negative bacilli. K. pneumoniae showed highest resistance against co-
amoxiclav and cephalosporins.  
Conclusion: The study revealed that ESBL producing strains were resistant to most of the beta-lactam antibiotics. This trend therefore 
has become a significant problem and can be controlled with continued surveillance or monitoring for rationally improved antibiotics 
usage, in order to prevent the drug resistance and re-emergence of infection. 
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Antimicrobial  resistance is the abil ity of bacteria to resist  the effects of an antibiotic or a mech anism that  blocks the 
inhibitory or kill ing effects of antibiotics (Popovic et al., 2007).  Beta-lactam antibiotics have been used as therapeutic agents 
since the 1940 as they are excellent  drugs because they are non-toxic and well  tolerated by most of the patients. The broad-
spectrum penicill ins were soon followed by a large number of cephalosporin. (Conly, 2002).  Antimicrobial  resistance caused 
by ESBL has been found in many pathogenic Gram-negative bacteria but they are most common in nosocomial isolates of K. 
pneumoniae (Cheesbrough, 2005).  Antimicrobial  resistance can also occur as a result  of random genetic mutations in bacteria, 
leading to variation in susceptibility within any bacterial  population (Favre-Bonte and Licht, 1999, Feglo et al., 2010). Klebsiella  
pneumoniae is a non-motile Gram-negative rod-shaped bacterium, non-spore forming bacill i,  which can grow both  
aerobically and anaerobically and are capsulated (Piranfar et al., 2014).  Klebsiella  species are known to cause a variety of human 
infections such as pneumonia,  septicaemia,  urinary tract  infections,  wound infection,  meningit is ,  throat infection,  intra-
abdominal abscess, brain abscess,  and device related infection (Andrade, 2014). 
 In recent studies most frequently identified bacteria were Escherichia coli  (64.56%) and Klebsiella pneumoniae 
(13.78%). E-coli  were 61.35% resistant to trimethoprim,  sulfamethoxazole and 49.6% resistant for Klebsiella spp.  Also 
intermediate resistance to nitrofurantion and tetracycline was also observed (Bergey's, 1994).  There is association of important co-
resistance and virulence factors in the K. pneumoniae, which makes this pathogen flourishing at infections and points to the quick evolution and 
expansion of this multi resistant as a virulent clone, leading to pan drug-resistant and persistent bacteria (Philipon et al 1989). 
 . 
 
Materials and Methods 
Samples Collection  
 
The study was conducted at Pakistan Institute of Medical Science Islamabad (PIMS) and a total of 200 clinical samples i.e., 
65 urine, 50 blood, 22 pus, 20 tracheal secretions, 20 tissue  and miscellaneous such as body fluids and infected wound swabs from out 
and in  patients of different wards were collected . The collected specimens were labeled, including the sample type, date, and 
patient’s gender, as per hospital record and transported to the laboratory within recommended time period and then processed for further studies. 
 





Sample Processing  
 
Freshly drawn 3-5 ml blood was immediately transferred to 50 ml of Brain Heart Infusion (BHI) broth, and incubated at  
37°C for 24 hours. Growth was sub-cultured on blood agar and MacConkey agar plates, and incubated for 24 hours at 37°C. For 
broth with no growth even after 48 hours were further incubated up to ten days, and observed the result. All urine samples were 
transferred to sterile tubes for centrifugation and streaked on Cysteine-Lactose-Electrolyte Deficient (CLED) medium. The plates 
were incubated for 24 to 48 hours at 37°C. The bacterial growth was sub-cultured on blood agar and MacConkey agar for further 
processing. Body fluids, pus, swabs samples were cultured on blood agar, MacConkey agar and XLD and incubated for 24 to 48 
hours at 37°C. The bacterial isolates from all type of samples were identified up to species level and the susceptibility testing was 
done using disc diffusion method. For short term storage isolates were preserved on the nutrient agar slants. These slants were incubated for 
overnight at 35oC and placed at 4oC. For long term preservations, the bacterial isolates were preserved at -70oC on nutrient broth containing 30% 
(v/v) glycerol in screw capped tubes. 
 
I dent i f i cat i on of  Bact er ia l  P ath oge ns   
                   
Isolated colonies, after purification, were initially Gram stained by using Bergey’s Manual of Bacteriology (Jarlier et al., 
1988). The isolates were characterized using biochemical tests i.e., triple sugar iron test, indole test, voges-Proskauer test (VP), motility test, 
citrate utilization test and oxidase test.  API 20E was used for the micro standard system of specific identification of K. pneumoniae  from the rest of 
the Gram negative rods using 20 microtubules with dehydrated substrates with the addition of bacterial suspension as inoculums (Al-Charrakh et al 
2011). An anaerobic environment was created in tubules containing ADH, LCD, ODH, H2S, and UREA with a drop of mineral oil overlay as per 
manufacturer’s instructions. The incubation box was then incubated at 37C for 24 hours. 
 
Antibiotic Sensitivity Test  
 
Antimicrobial susceptibility testing was carried out by the standard Kirby-Bauer disk diffusion method on Muller-Hinton agar following 
guidelines provided by Clinical and Laboratory Standards Institute (CLSI) 2010. 
 
Detection of ESBL  
 
For detection of ESBL-production, double disc method of (Jarlier et  al  1988) was used to observe the ESBL production. 
The identified Gram negative organisms were swabbed onto a Mueller-Hinton agar plate. A susceptibility disc of co-amoxiclav 
(20µg amoxicillin/ 10µg clavulanic acid) was placed in the center of the agar surface. The discs of ceftriaxon and ceftazidime 
(30µg each) were arranged in such a way that the distance between the central disc and surrounding d iscs was approximately 30 
mm. After 30 minutes of pre-incubation time, the plates were incubated aerobically at 35 C for 24hrs. If the inhibition zone around 
one or more cephalosporin discs was extended on the side nearest to the co-amoxiclav disc, the organism showed an ESBL 
production. If no extension of zones of third generation of cephalosporin towards co-amoxiclav disc was observed, the organisms 
were considered as non-producer of ESBLs.  
 
 
Results and Discussion 
ESBL Production in K.  Pneumoniae 
 
Out of 200 ß-lactamase (ESBL) producing isolates, 175 (87.5%) ESBL positive and 25 (12.55%) ESBL negative organisms were detected 
by double disk diffusion method (Figure 1) and this pattern was similar as in another finding by Al-Charrakh et al., 2011. 
 
Figure 1: The total samples distribution pattern for K. Pneumoniae isolates 





Figure 2: Gender wise distribution of K. Pneumoniae infection 
 
                                     





Isolates were identified by their growth on different media, MacConkey agar, blood agar, xylose lysine deoxicholate (XLD) and cysteine 
lactose electrolyte deficient (CLED). Colonies were observed after 24 hours of incubation as pink , bright yellow and whitish grey colonies on 
MacConky agar, XLD, CLED and blood agar; respectively. These observations  are generally noted as similarly observed in a study by (Shah et al., 
2000, Mumtaz et al., 2008).   
                        
 





   
 
Figure 4: Growth of Klebsiella pneumoniae  on MacConky and Blood agar 
 
                    




Figure 5: Growth of Klebsiella pneumoniae on CLED and XLD culture media 
 
 Gram Staining Result 
  
              All 200 samples were Gram stained to observe the morphological characteristics of K. Pneumoniae under microscope. It was observed that 
K. Pneumoniae was Gram negative as it appeared thick pink rod as shown in (Figure 6), these results are supported by other researchers and are in 














Biochemical Characteristics of K. Pneumoniae 
 
For biochemical characterization, a series of biochemical tests for K. pneumoniae were manually performed such as citrate, VP, TSI, 
motility, indole and oxidase and were compared with API 20 E analysis. Our results were compatible with (Winn et al., 2006, Murray et al., 2007). 
                
Table: 1. Biochemical Characteristics of K. pneumoniae 
 
Biochemical Characteristics 
Test    Results Change In Growth Media 
 Citrate      +ive Green to Blue 
 Motility    -ive No Turbidity no Growth 
 Indole    -ive Oily Band on Top Not Red In Colour 
 Voges-Proskauser    +ive Pink-Red in colour 
 Oxidase    -ive No color change 
 Triple Sugar Iron    +ive Light Pink(alkaline), 
 
 
                                            
 
Figure 7:  Voges-Proskauer , Citrate  , Indole and Motility tests 
 
 
Results on API 20E System 
 
 The biochemically identified samples of K. pneumoniae when analyzed on API 20E system on an API strip, a conversion  numerical value 
was obtained. The generated number from API 20E system for K .pneumoniae was then checked in the catalogue book and was identified 95 percent 
up to species level. (Figure 8) Results showed similarity with findings by (Carson et al., 2001). 
 
 
Figure 8: Results of API20E for confirmation of K. Pneumoniae 
 
Antibiotic Susceptibility Pattern of Isolates 
  
 In the present study, most commonly used antibiotics discs were subjected to determine the Klebsiella pneumonia 
sensitivity. Antibiotic sensitivity of K. pneumoniae was observed by disc diffusion method in which fourteen different antibiotics were applied. The 
sensitivity of K. pneumoniae was checked with help of list of break points of zone of inhibition and to consider resistant one when zone of inhibition 
did not fall into the values of break points. The results showed that among fourteen conventional drugs K. pneumoniae showed highest 




resistance against co-amoxiclav, i.e., 100%. The next highest resistance was for cephalosporin, such as ceftazidime, ceftriaxone 
followed by Piperacillin-tazobactum, norfloxacin, cefoperazon+sulbactum, gentamycin, tobramycine, amikacin, piperacillin , imipenem 
and meropenem. Isolates were found to be resistant to all classes of antibiotics except polymixin B. The (Al-Zahrani et al., 2005), also determined 
antimicrobial sensitivity test by using different antibiotics and found that K. pneumoniae was sensitive to meropenem, imipenem. The resistance 
against different similar drugs was also reported by (Chaikittisuk et al., 2007). 
 
Table 2: Antibiotic sensitivity pattern of specimens referred from surgical ward 
 
         Antibiotics  Resistance 
Count (%age) 
 Intermediat 
  Count (%age) 
 
Sensitive 






Amoxicillin  52(100) 0(0.00) 0(0.00)   52 
 Ceftazidime  44(89.7) 2(4.0) 3(6.10)    49 
Ceftriaxone  54(100) 0(0.00) 0(0.00)    54 
Tazobactum  48(84.2) 3(5.2) 6(10.5) 57 
Norithindrone 35(83) 2(4.7) 5(11.5) 42 
Gentamicin  30(60) 0(0.00) 20(40) 50 
Tobramycin  24(40) 1(1.6) 35(58) 58 
Amikacin  19(38) 0(0.00) 31(62) 50 
Piperacillin  17(34.6) 10(20.0) 22(44.8) 49 
Levofloxacine  5(9.0) 0(0.00) 50(90) 55 
   Meropenem  2(3.8) 0(0.00) 50(96) 52 
Polymixine B  0(0.00) 0(0.00) 50(100) 50 
 
Table: 3: Antibiotic sensitivity pattern of specimens referred from medical ward 
 
         Antibiotics  Resistance 
Count (%age) 
 
 Intermediat  









Amoxicillin 50(100) 0(0.00) 0(0.00)   50 
Piperacillin  47(95.5) 1(2.0) 1(2.0) 49 
Ceftriaxone  45(93.7) 2(4.1) 1(2.0) 48 
Tazobactum  35(89.7) 1(2.5) 3(7.6) 39 
Norithindrone 40(83) 1(2.0) 7(14) 48 
Gentamicin  20(39) 1(1.9) 28(54) 49 
Tobramycin  22(48) 2(4.4) 23(51) 47 
Amikacin  20(41) 0(0.00) 28(58) 48 
Piperacillin  20(34) 9(15) 29(50) 58 
Levofloxacine  5(9.0) 0(0.00) 50(90) 55 
  Meropenem  3(6.5) 0(0.00) 43(93) 46 
Polymixine B  0(0.00) 0(0.00) 49(100) 49 
 
                                 Table: 4: Antibiotic sensitivity pattern of specimen’s referred from outpatient department 
 













Amoxicillin 55(100) 0(0.00) 0(0.00) 55 
Ceftazidime  50(89) 2(3.5) 4(7.1) 56 
Ceftriaxone  49(96) 1(1.9) 1(1.9) 51 
Tazobactum  48(87.5) 2(4.0) 4(8.0) 54 
Norithindrone  57(93) 1(1.6) 3(4.9) 61 
Gentamicin  26(53) 0(0.00) 23(46.9) 49 
Tobramycin  24(52) 1(2.0) 27(58) 52 
Amikacin  22(36) 0(0.00) 39(63.9) 61 
Piperacillin  19(38) 22(11) 20(40) 61 
Levofloxacine  4(8.6) 1(2.1) 41(89) 45 
    Meropenem  4(7.8) 0(0.00) 53(92) 57 
Polymixine B  0(0.00) 0(0.00) 50(100) 50 







Table: 5: Antibiotic sensitivity pattern of specimens referred from intensive care unit 
 
         Antibiotics  Resistance 
 Count (%age) 
 
 Intermediat 
  Count (%age) 
 
Sensitive 






Amoxicillin  43(95) 0(0.00) 2(4.4) 45 
Ceftazidime  43(97) 0(0.00) 1(2.0) 44 
Ceftriaxone  47(100) 0(0.00) 0(0.00) 47 
Tazobactum  51(91) 2(3.5) 3(5.3) 56 
Norithindrone  43(87) 1(2.0) 5(10) 49 
Gentamicin  24(45) 2(3.7) 26(46) 52 
Tobramycin  27(57) 0(0.00) 20(42) 47 
Amikacin  14(34) 0(0.00) 27(65.8) 41 
Piperacillin  14(32.5) 10(23) 19(44) 43 
Levofloxacine  6(10.9) 0(0.00) 49(89) 55 
  Meropenem 3(6.6) 0(0.00) 52(93.3) 55 
Polymixine B  0(0.00) 0(0.00) 50(100) 50 
 
 Acquired bacterial resistance is common among clinical isolates from heal thy persons as well as patients having 
community-acquired infections in developing countries. K. pneumoniae was observed to be resistant against ciprofloxacin, 
amoxacilline-clavulanic acid and gentamicin. Polymixin B and meropenem were the drugs considerably effective against K. 
pneumoniae along with other high spectrum third generation antibiotics. In conclusion, antimicrobial resistance is widespread among 
hospital and community-acquired pathogens in Pakistan. Monitoring ESBL production and antimicrobial susceptibility testing are necessary 
to reduce the burden of increasingly resistant pathogens (Asti 2013). Therefore, the antibiotic stewardship guidelines need to be recommended and 
strictly adopted in a comprehensive control program to reduce the high levels of bacterial antibiotic resistance (Mohanalakshmi et al. 2014). In this 
study, the prevalence of the ESBLs was highest in K. pneumonia which is an indication of increased resistance. However, in the 
industrialized world, education of the medical professionals regarding the use of antimicrobial agents seems to be the single most 




 The study revealed that ESBL producing strains were resistant to most  of the beta-lactam antibiotics. This trend, therefore, 
has become a significant problem and can be controlled with continued surveillance or monitoring for rationally improved antibiotics 
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